‘We are working towards possible approvals of adapted vaccines in September,’ said EMA’s Executive Director, Emer Cooke, noting that ‘our human medicines committee is currently reviewing data for two adapted vaccines. National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. The table below lists the COVID-19 vaccines that are authorised for use in the EU, including originally authorised and adapted vaccines.Īdapted vaccines are intended to provide broader protection against different virus variants following initial vaccination.Ĭompanies marketing originally authorised vaccines can apply to change the marketing authorisation to include an adapted version, which is shown in italics in the table below. EMA’s human medicines committee has concluded that a booster dose of COVID-19 Vaccine Janssen may be considered at least two months after the first dose in people aged 18 years and above. The latest ECDC / EMA advice comes amid work to adapt vaccines for the Omicron variants of concern. EMA’s human medicines committee has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 5 to 11.The vaccine, developed by BioNTech and Pfizer, is already approved for use in adults and children aged 12 and above.
0 kommentar(er)
